Apollo Hospitals

What does Apollo Hospitals do?

Apollo Hospitals Enterprise Ltd. is a leading private healthcare provider in Asia, with a market cap of Rs 99,858 Cr and reported net sales of 5,592 Cr and net profit of 390 Cr for March 2025. The company has a P/E ratio of 68.00 and a return on equity of 17.61%.

Overview: <BR>Apollo Hospitals Enterprise Ltd. is a leading private sector healthcare provider in Asia, operating within the hospital industry and categorized as a large-cap company.<BR><BR>History: <BR>Apollo Hospitals Enterprise Ltd. was incorporated in an unspecified year and has maintained its status as a prominent player in the healthcare sector. The latest quarterly results reported are for March 2025, showing significant sales and profit figures.<BR><BR>Financial Snapshot: <BR>- Net Sales: 5,592 Cr (Quarterly Results - Mar 2025) <BR>- Net Profit: 390 Cr (Quarterly Results - Mar 2025) <BR>- Market Cap: Rs 99,858 Cr (Large Cap) <BR><BR>Key Metrics: <BR>- P/E: 68.00 <BR>- Industry P/E: 54 <BR>- Dividend Yield: 0.28% <BR>- Debt-Equity: 0.62 <BR>- Return on Equity: 17.61% <BR>- Price to Book: 12.04 <BR><BR>Contact Details: <BR>Address: No 19 Bishop Garden, Raja Annamalaipuram Chennai Tamil Nadu : 600028 <BR>Tel: 91-44-28290956/28293896 <BR>Email: apolloshares@vsnl.net <BR>Website: http://www.apollohospitals.com

When is the next results date for Apollo Hospitals?

No Upcoming Board Meetings

Who are in the management team of Apollo Hospitals?

As of March 2023, the management team of Apollo Hospitals includes Prathap C Reddy (Executive Chairman), Preetha Reddy (Executive Vice Chairperson), Suneeta Reddy (Managing Director), and several independent directors, playing a key role in the company's strategic direction and governance.

As of March 2023, the management team of Apollo Hospitals includes:<BR><BR>1. Prathap C Reddy - Executive Chairman<BR>2. Preetha Reddy - Executive Vice Chairperson<BR>3. Suneeta Reddy - Managing Director<BR>4. Sangita Reddy - Joint Managing Director<BR>5. Shobana Kamineni - Executive Vice Chairperson<BR>6. S M Krishnan - Senior Vice President & Company Secretary<BR>7. Vinayak Chatterjee - Independent Director<BR>8. Murali Doraiswamy - Independent Director<BR>9. V Kavitha Dutt - Independent Director<BR>10. M B N Rao - Lead Independent Director<BR>11. Som Mittal - Independent Director<BR>12. Rama Bijapurkar - Independent Director<BR><BR>This diverse team plays a crucial role in the strategic direction and governance of the company.

Who are the peers of the Apollo Hospitals?

Apollo Hospitals' peers include Max Healthcare, Fortis Health, Narayana Hrudaya, and others. Key metrics show excellent management risk and capital structure at several peers, with Krishna Institu. leading in 1-year returns at 85.23%, while Apollo Hospitals has a 1-year return of 16.20%.

Peers: The peers of Apollo Hospitals are Max Healthcare, Fortis Health., Narayana Hrudaya, Global Health, Aster DM Health., Krishna Institu., Rainbow Child., Dr Agarwal's Hea, Jupiter Life Lin, and Health.Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Narayana Hrudaya, Global Health, Krishna Institu., Rainbow Child., Dr Agarwal's Hea, Jupiter Life Lin, and the rest. Good growth is noted at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Dr Agarwal's Hea, and the rest, while Average growth is found at Fortis Health., Global Health, and the rest. Average capital structure is seen at Apollo Hospitals, while Excellent capital structure is noted at Max Healthcare, Global Health, Krishna Institu., Jupiter Life Lin, and the rest, and Below Average capital structure is observed at Aster DM Health.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Krishna Institu. at 85.23%, while the lowest is Dr Agarwal's Hea with N/A, and Apollo Hospitals has a 1-year return of 16.20%. Additionally, Aster DM Health. and Dr Agarwal's Hea have negative six-month returns.

Who are the top shareholders of the Apollo Hospitals?

The top shareholders of Apollo Hospitals include M/s. Pcr Investments Ltd with 18.93%, Foreign Institutional Investors holding 43.49%, and mutual funds with 15.94%. The highest public shareholder is Mirae Asset Midcap Fund at 2.21%, while individual investors own 3.98%.

The top shareholders of Apollo Hospitals include a mix of institutional and individual investors. The largest shareholder is M/s. Pcr Investments Ltd, which holds 18.93% of the company. Foreign Institutional Investors (FIIs) are significant stakeholders, collectively holding 43.49%. Additionally, mutual funds are represented by 324 schemes, accounting for 15.94% of the shares. The highest public shareholder is Mirae Asset Midcap Fund, with a holding of 2.21%. Individual investors collectively own 3.98% of the company.

How big is Apollo Hospitals?

As of 24th July, Apollo Hospitals Enterprise Ltd. has a market capitalization of 106,791.00 Cr, with recent net sales of 21,794.00 Cr and a net profit of 1,445.90 Cr. The company reported shareholder's funds of 6,935.40 Cr and total assets of 16,742.20 Cr for the annual period ending in March 2024.

As of 24th July, Apollo Hospitals Enterprise Ltd. has a market capitalization of 106,791.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, Apollo Hospitals reported Net Sales of 21,794.00 Cr and a Net Profit of 1,445.90 Cr.<BR><BR>For the latest annual period ending in March 2024, the company had Shareholder's Funds amounting to 6,935.40 Cr and Total Assets of 16,742.20 Cr.

Is Apollo Hospitals overvalued or undervalued?

As of October 30, 2025, Apollo Hospitals is considered undervalued with an attractive valuation grade, featuring a PE ratio of 71.16, a lower PEG ratio of 1.37 compared to peers, and an 11.30% return over the past year, outperforming the Sensex's 5.58%.

As of 30 October 2025, Apollo Hospitals has moved from a fair to an attractive valuation grade, indicating a shift in its perceived value. The company is currently considered undervalued, particularly when compared to its peers. Key ratios include a PE ratio of 71.16, an EV to EBITDA of 36.59, and a ROE of 17.61%. <BR><BR>In comparison to its peers, Apollo Hospitals stands out with a lower PEG ratio of 1.37, while competitors such as Max Healthcare and Fortis Health are deemed very expensive with PE ratios of 94.85 and 85.21, respectively. Additionally, despite a slight decline in the past week, Apollo Hospitals has outperformed the Sensex over the past year with a return of 11.30% compared to the Sensex's 5.58%, reinforcing its attractive valuation in the current market.

How has been the historical performance of Apollo Hospitals?

Apollo Hospitals has shown consistent growth in net sales and profitability, with net sales increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25, and profit after tax rising from 199.18 Cr to 1,472.10 Cr in the same period. The company has also improved its earnings per share from 16.97 to 100.55 and demonstrated strong asset growth.

Answer:<BR>The historical performance of Apollo Hospitals shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Apollo Hospitals has demonstrated significant growth in net sales, increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25. The total operating income followed a similar trend, reaching 21,794.00 Cr in Mar'25, up from 16,612.50 Cr in Mar'23. The operating profit (PBDIT) also rose notably, from 1,095.10 Cr in Mar'19 to 3,222.10 Cr in Mar'25, reflecting an operating profit margin of 13.87% in the latest year. Profit before tax surged to 2,006.10 Cr in Mar'25, with profit after tax reaching 1,472.10 Cr, marking a significant increase from 199.18 Cr in Mar'19. The earnings per share (EPS) improved dramatically from 16.97 in Mar'19 to 100.55 in Mar'25. On the balance sheet, total assets grew from 11,288.80 Cr in Mar'20 to 20,644.30 Cr in Mar'25, while total liabilities increased from 11,288.80 Cr to 20,644.30 Cr in the same period. Cash flow from operating activities has also shown positive growth, reaching 2,136.00 Cr in Mar'25, contributing to a closing cash balance of 578.00 Cr. Overall, Apollo Hospitals has exhibited robust financial performance with increasing revenues, profits, and asset growth over the years.

Is Apollo Hospitals technically bullish or bearish?

As of December 3, 2025, Apollo Hospitals shows a mildly bearish trend, driven by bearish signals from the MACD, KST, and OBV on weekly and monthly charts, despite some mixed indicators from Bollinger Bands and daily moving averages.

As of 3 December 2025, the technical trend for Apollo Hospitals has changed from sideways to mildly bearish. The current technical stance is mildly bearish. Key indicators driving this stance include the MACD on both weekly and monthly time frames showing mildly bearish signals, along with the KST and OBV also indicating mild bearishness on the weekly and monthly charts. The Bollinger Bands present a mixed view, being bearish on the weekly but mildly bullish on the monthly. The daily moving averages suggest a mildly bullish position, but this is overshadowed by the overall bearish indicators in the longer time frames.

Are Apollo Hospitals Enterprise Ltd. latest results good or bad?

Apollo Hospitals Enterprise Ltd. reported strong Q3 FY26 results, with a net profit of ₹477.20 crore, a 25.98% year-on-year increase, and record net sales of ₹6,303.50 crore. While the operational performance is solid, the stock trades below its 52-week high, indicating some valuation concerns.

Apollo Hospitals Enterprise Ltd. has reported solid results for the latest quarter, showcasing strong operational performance. The consolidated net profit for Q3 FY26 reached ₹477.20 crore, reflecting a significant year-on-year increase of 25.98% and a quarter-on-quarter growth of 10.26%. Additionally, net sales hit an all-time high of ₹6,303.50 crore, marking a 12.78% increase year-on-year and a 7.90% rise from the previous quarter.<BR><BR>The operating margin also showed improvement, reaching 14.93%, which is higher than both the previous quarter and the same quarter last year. This indicates effective cost management and operational efficiency. Furthermore, the return on equity (ROE) has improved to 18.39%, the highest in recent periods, demonstrating the company's ability to generate returns for its shareholders.<BR><BR>Despite these positive results, the stock has been trading below its 52-week high, suggesting some valuation challenges. Overall, the latest results can be considered good, as they highlight the company's operational strength and ability to capitalize on the growing demand for healthcare in India. However, investors should remain cautious about the high valuation multiples and recent stock performance relative to peers.

Should I buy, sell or hold Apollo Hospitals Enterprise Ltd.?

Has Apollo Hospitals Enterprise Ltd. declared dividend?

Yes, Apollo Hospitals Enterprise Ltd. has declared a dividend of 200%, amounting to ₹10 per share, with an ex-date of February 16, 2026. The dividend yield is 0.25%, contributing to positive total returns across various periods.

Apollo Hospitals Enterprise Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 10<BR>- Ex-date: 16 Feb 26<BR><BR>Dividend Yield: 0.25%.<BR><BR>Total Returns by Period:<BR>In the 3 Months period, the price return was 0.52%, the dividend return was 0.13%, resulting in a total return of 0.65%.<BR><BR>In the 6 Months period, the price return was 4.21%, the dividend return was 0.25%, leading to a total return of 4.46%.<BR><BR>In the 1 Year period, the price return was 17.92%, the dividend return was 0.32%, culminating in a total return of 18.24%.<BR><BR>In the 2 Years period, the price return was 13.99%, the dividend return was 0.58%, resulting in a total return of 14.57%.<BR><BR>In the 3 Years period, the price return was 70.71%, the dividend return was 1.23%, leading to a total return of 71.94%.<BR><BR>In the 4 Years period, the price return was 66.7%, the dividend return was 1.54%, culminating in a total return of 68.24%.<BR><BR>In the 5 Years period, the price return was 174.48%, the dividend return was 2.57%, resulting in a total return of 177.05%.<BR><BR>Overall, Apollo Hospitals Enterprise Ltd. has declared a significant dividend, which contributes to its total returns across various periods, indicating a strong performance in both price appreciation and dividend distribution.

Why is Apollo Hospitals Enterprise Ltd. falling/rising?

As of 17-Mar, Apollo Hospitals Enterprise Ltd. is seeing a slight stock price increase to 7,503.20 after a trend reversal following four days of decline. Despite recent underperformance relative to its sector, strong financial fundamentals and rising investor interest suggest a positive outlook.

As of 17-Mar, Apollo Hospitals Enterprise Ltd. is experiencing a slight rise in its stock price, currently at 7,503.20, with a change of 10.35 (0.14%) upward. This increase follows a trend reversal, as the stock has gained after four consecutive days of decline. Despite this recent uptick, the stock has underperformed its sector by 0.41% today.<BR><BR>The stock's performance over various periods shows a mixed picture. Over the past week, it has fallen by 3.80%, while over the past month, it has decreased by 1.23%. However, on a year-to-date basis, the stock has risen by 6.54%, significantly outperforming the Sensex, which has declined by 10.74% in the same timeframe. Over the last year, Apollo Hospitals has delivered a robust return of 21.95%, while the Sensex has only increased by 2.56%.<BR><BR>Several positive factors contribute to the stock's resilience. The company demonstrates high management efficiency with a return on capital employed (ROCE) of 16.84% and a low debt to EBITDA ratio of 1.48 times, indicating a strong ability to service its debt. Additionally, the company has shown healthy long-term growth, with net sales growing at an annual rate of 17.93% and operating profit at 39.35%. The company has also declared positive results for the last nine consecutive quarters, further bolstering investor confidence.<BR><BR>Moreover, there is rising investor participation, as evidenced by a delivery volume of 3.23 lacs on March 16, which has increased by 26.63% compared to the five-day average. This suggests a growing interest in the stock, despite its recent underperformance relative to the sector.<BR><BR>In summary, while Apollo Hospitals Enterprise Ltd. has faced some short-term declines, its recent price increase can be attributed to a trend reversal, strong financial fundamentals, and increasing investor participation, which collectively support a positive outlook for the stock.

Why is Apollo Hospitals Enterprise Ltd. falling/rising?

As of 18-Mar, Apollo Hospitals Enterprise Ltd. is seeing a stock price decline to 7,468.95, down 0.46%. This drop is due to underperformance compared to the benchmark and sector, decreased investor participation, and short-term weakness, despite strong fundamentals.

As of 18-Mar, Apollo Hospitals Enterprise Ltd. is experiencing a decline in its stock price, currently at 7,468.95, reflecting a change of -34.25 (-0.46%). This decrease can be attributed to several factors. Over the past week, the stock has underperformed, showing a decline of 2.85%, while the benchmark Sensex has only decreased by 0.21%. Additionally, the stock's performance today has underperformed its sector by 1.76%.<BR><BR>Investor participation appears to be falling, as evidenced by a delivery volume of 2.16 lacs on 17 March, which has dropped by 23.2% compared to the 5-day average delivery volume. Although the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, indicating a short-term weakness.<BR><BR>Despite these negative indicators, the company has shown strong fundamentals, including a high return on capital employed (ROCE) of 16.84% and a low debt to EBITDA ratio of 1.48 times. However, the current market sentiment appears to be overshadowing these strengths, contributing to the stock's decline.

Why is Apollo Hospitals Enterprise Ltd. falling/rising?

As of 19-Mar, Apollo Hospitals Enterprise Ltd. is experiencing a stock price decline to Rs 7,262.35, reflecting a -2.77% change. This trend is part of a broader bearish movement, although the company maintains strong fundamentals and has shown significant long-term growth.

As of 19-Mar, Apollo Hospitals Enterprise Ltd. is experiencing a decline in its stock price, currently at Rs 7,262.35, which reflects a change of -206.6 or -2.77%. This downward movement is part of a broader trend, as the stock has been losing value for the last two days, with a total decline of -3.21% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>The performance of the stock over the past week shows a decrease of -4.12%, which is worse than the benchmark Sensex's decline of -2.40%. Over the past month, the stock has also fallen by -4.29%, while the Sensex has dropped by -10.05%, suggesting that Apollo Hospitals is performing relatively better than the broader market in the short term. However, the sector itself, Hospital & Healthcare Services, has seen a decline of -2.8%, contributing to the negative sentiment surrounding the stock.<BR><BR>Despite these recent declines, there are positive factors that indicate potential for recovery. The company has demonstrated strong financial health with a high return on capital employed (ROCE) of 16.84%, a low debt-to-EBITDA ratio of 1.48 times, and consistent positive results over the last nine quarters. Furthermore, the stock has shown impressive long-term growth, with a 67.01% increase over the past three years and a 147.37% increase over the last five years.<BR><BR>In summary, the current fall in Apollo Hospitals' stock price can be attributed to recent negative performance trends, both in the stock itself and the broader sector, despite the company's strong fundamentals and historical performance.

Why is Apollo Hospitals Enterprise Ltd. falling/rising?

As of 20-Mar, Apollo Hospitals Enterprise Ltd. has seen its stock price rise to 7,345.65, reflecting a 1.15% increase after a trend reversal. Despite recent declines over the past week and month, the stock has shown a year-to-date gain of 4.30% and a 13.47% return over the past year, supported by strong fundamentals and high institutional confidence.

As of 20-Mar, Apollo Hospitals Enterprise Ltd. is experiencing a rise in its stock price, currently at 7,345.65, with an increase of 83.3 (1.15%). This upward movement follows a trend reversal after two consecutive days of decline. The stock outperformed its sector by 0.59% today and reached an intraday high of Rs 7447.95, reflecting a gain of 2.56%.<BR><BR>Despite the recent positive performance, the stock has shown a decline over the past week and month, with returns of -2.71% and -3.49%, respectively. However, year-to-date, it has increased by 4.30%, and over the past year, it has generated a return of 13.47%. The company's strong fundamentals, including a high return on capital employed (ROCE) of 16.84% and a low debt to EBITDA ratio of 1.48 times, contribute to its attractiveness as an investment. Additionally, the company has consistently reported positive results for the last nine quarters, indicating robust operational performance.<BR><BR>While the stock is currently trading below its moving averages, the overall market-beating performance in the long term and high institutional holdings at 65.27% suggest confidence among larger investors. The stock's ability to generate significant returns in the past year, alongside a healthy growth in net sales and operating profit, supports its rising price despite recent volatility.

Which are the latest news on Apollo Hospitals?

Which are the latest news on Apollo Hospitals?

Which are the latest news on Apollo Hospitals?